Who are polyethylene glycol alone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pizensy, Miralax, Cephulac, Milk of Magnesia, Oral sulfate solution (OSS), Miralax (PEG 3350).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyethylene-glycol-alone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

polyethylene glycol alone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

polyethylene glycol alone (polyethylene glycol alone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative. Area: Gastroenterology.

marketed Osmotic laxative Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

polyethylene glycol alone (polyethylene glycol alone) — Department of Medical Services Ministry of Public Health of Thailand. Polyethylene glycol (PEG) is an osmotic laxative that draws water into the intestinal lumen to soften stool and promote bowel movements.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
polyethylene glycol alone TARGET	polyethylene glycol alone	Department of Medical Services Ministry of Public Health of Thailand	marketed	Osmotic laxative
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Oral sulfate solution (OSS)	Oral sulfate solution (OSS)	Bo-In Lee	marketed	Osmotic laxative
Miralax (PEG 3350)	Miralax (PEG 3350)	Brooke Army Medical Center	marketed	Osmotic laxative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-03-09 — Miralax · 10780112 · US
2032-03-09 — Miralax · 11529368 · US
2032-03-09 — Miralax · 10792306 · US
2032-03-25 — Miralax · 10646512 · US
2032-08-11 — Miralax · 9592252 · US
2033-09-10 — Miralax · 9326969 · US
2033-09-10 — Miralax · 9707297 · US
2033-09-10 — Miralax · 8999313 · US
2033-09-10 — Miralax · 10918723 · US
2033-09-10 — Miralax · 10016504 · US

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). polyethylene glycol alone — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-alone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab